Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2026-04-06

Clinical Trial Update: Natural History of Severe Allergic Inflammation and Reactions

View source ↗

Summary

This update describes the completed observational study on the natural history of severe allergic inflammation across several rare immunodermatologic conditions…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: PGM3 Deficiency, Eosinophilic and/or Atopic Dermatitis | Status: COMPLETED